Department of Anaesthesiology, Kanagawa Children's Medical Centre, Yokohama, Japan.
Anaesthesia. 2014 Dec;69(12):1388-96. doi: 10.1111/anae.12788. Epub 2014 Jul 3.
The purpose of this meta-analysis was to determine the efficacy of lidocaine in preventing laryngospasm during general anaesthesia in children. An electronic search of six databases was conducted. The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines were adhered to. We included randomised controlled trials reporting the effects of intravenous and/or topical lidocaine on the incidence of laryngospasm during general anaesthesia. Nine studies including 787 patients were analysed. The combined results demonstrated that lidocaine is effective in preventing laryngospasm (risk ratio (RR) 0.39, 95% CI 0.24-0.66; I(2) = 0). Subgroup analysis revealed that both intravenous lidocaine (RR 0.34, 95% CI 0.14-0.82) and topical lidocaine (RR 0.42, 95% CI 0.22-0.80) lidocaine are effective in preventing laryngospasm. The results were not affected by studies with a high risk of bias. We conclude that, both topical and intravenous lidocaine are effective for preventing laryngospasm in children.
本荟萃分析的目的是确定利多卡因在预防全身麻醉期间儿童喉痉挛的疗效。对六个数据库进行了电子检索。我们遵循了系统评价和荟萃分析的首选报告项目(PRISMA)指南。我们纳入了报告静脉和/或局部利多卡因对全身麻醉期间喉痉挛发生率影响的随机对照试验。分析了 9 项研究共 787 名患者。综合结果表明,利多卡因可有效预防喉痉挛(风险比(RR)0.39,95%置信区间(CI)0.24-0.66;I²=0)。亚组分析显示,静脉内利多卡因(RR 0.34,95%CI 0.14-0.82)和局部利多卡因(RR 0.42,95%CI 0.22-0.80)均能有效预防喉痉挛。结果不受高偏倚风险研究的影响。我们的结论是,局部和静脉内利多卡因均能有效预防儿童喉痉挛。